University of Lausanne Hospitals
Lausanne, 1011, Switzerland
Location status: Recruiting
NCT Number: NCT05236348
This study with N = 225 participants (1 cohort of a minimum of 85 and maximum of 140 participants, and an additional cohort with 85 participants) over 9 visits has been designed to assess the accuracy of Aktiia.product-us systolic and diastolic blood pressure measurements against double-auscultation reference measurements. In order to induce blood pressure changes and to simulate ambulatory scenarios, the study participants will be asked to perform a set of activities, involving body position changes and physical exercises. Additionally, this study will compare the heart rate measured by Aktiia.product-us against the reference readings provided by a finger pulse oximeter (as per ISO80601-2-61). The reliability of the auscultation readings will be controlled with simultaneous volume-clamp measurements.
Interested in participating?
Request Info21 year–85 year
All sexes
Interventional
Not applicable
Lausanne, 1011, Switzerland
Location status: Recruiting
According to the World Health Organization, by 2025 hypertension will affect 1.5 billion adults worldwide. Half of the adult population suffering from hypertension is currently not diagnosed and half of the treated population is not at the defined target of BP.
Widespread use of out-of-office Blood Pressure measurement is one of the proposed strategies to fight against hypertension worldwide.
Aktiia S.A. has developed an intermittent automated non-invasive cuffless blood pressure monitor, determining the values of the systolic blood pressure, the diastolic blood pressure and the heart rate. This miniature device is comfortably positioned with a bracelet on a user's wrist.
The goal of this study is to establish a reasonable assurance of safety and effectiveness with Aktiia OBPM system for monitoring blood pressure in home use.
In particular, the study will collect data from subjects by means of the device under test and collect data from subjects by means of double-auscultation, pulse oximetry and volume-clamp BP reading while subjects wear the devices at different body positions and induce Blood Pressure changes, during eight visits that will be held over the span of seven days, and generate performance reports.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The study will collect data from subjects by means of the device under test and collect data from subjects by means of double-auscultation, pulse oximetry and volume-clamp BP reading while subjects wear the devices at different body positions and induce BP changes, during eight visits that will be held over the span of seven days, and generate performance reports.
Other names: Aktiia bracelet, Aktiia product, Aktiia.product
Time frame: 1 week
The mean value of the differences between Aktiia.product-us and double auscultation blood pressure measurements.
Time frame: 1 week
The standard deviation of the differences between Aktiia.product-us and double auscultation blood pressure measurements.
Time frame: 1 week
The root-mean-square difference between the Aktiia.product-us heart rate determinations and the reference method.
Contact information is provided by the study sponsor or research team.
Aktiia SA
Industry
Single-center Prospective Clinical Trial to Validate the Performance of the Aktiia Optical Blood Pressure Monitoring (OBPM) Device at the Wrist Against Double Auscultation
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05979168
Behavior, Blood Pressure
Kathmandu, Bagmati, Nepal
View Trial DetailsNCT06868719
Aging, Blood Pressure
Bloomington, Indiana, United States
View Trial DetailsNCT06689930
Blood Pressure, Cardiovascular Diseases
Madison, Wisconsin, United States
View Trial DetailsNCT06283758
Blood Pressure, Cardiovascular Diseases
Nanjing, Jiangsu, China
View Trial Details